Emerging roles of dehydrogenase/reductase (DHRS) in cancer

Jun Huang1, Chenpeng Tang1, Xue Chen2

  • 1Hunan Key Laboratory of Oncotarget Gene, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan 410013, PR China; Key Laboratory of Carcinogenesis and Invasion, Chinese Ministry of Education, Cancer Research Institute, School of Basic Medicine, Central South University, Changsha, Hunan 410078, PR China.

Insights

The dehydrogenase/reductase (DHRS) family, part of the SDR superfamily, plays roles in metabolism and is increasingly linked to cancer progression. This review highlights known and emerging cancer-associated functions of DHRS members.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • The dehydrogenase/reductase (DHRS) family is a significant part of the short-chain dehydrogenase/reductase (SDR) superfamily.
  • DHRS proteins are crucial for metabolizing lipids, steroids, and retinol.
  • The DHRS family has over 12 members, with several implicated in cancer.

Purpose of the Study:

  • To provide a comprehensive overview of the DHRS family.
  • To highlight the known and emerging roles of DHRS members in cancer progression.
  • To consolidate current knowledge on DHRS family functions in tumorigenesis.

Main Methods:

  • Literature review
  • Bioinformatic analysis (implied)
  • Functional annotation of DHRS members

Main Results:

  • Specific DHRS members (DHRS2, DHRS3/4/9/13, DHRS8/10/11, DHRS6) have characterized roles in lipid, retinoic acid, and steroid metabolism, and iron homeostasis, with links to cancer.
  • Emerging evidence suggests broader associations between other DHRS family members and cancer.
  • The diverse metabolic functions of DHRS proteins underscore their potential impact on cellular processes relevant to cancer.

Conclusions:

  • The DHRS family represents a critical group of enzymes with diverse metabolic functions.
  • Dysregulation of DHRS members is increasingly recognized as a factor in tumorigenesis and cancer progression.
  • Further research into the less-characterized DHRS members may reveal novel therapeutic targets for cancer.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Role of Reduced Coenzymes NADH and FADH₂01:29

Role of Reduced Coenzymes NADH and FADH₂

The energy released from the breakdown of the chemical bonds within nutrients can be stored either through the reduction of electron carriers or in the bonds of adenosine triphosphate (ATP). In living systems, a small class of compounds functions as mobile electron carriers, molecules that bind to and shuttle high-energy electrons between compounds in pathways. The principal electron carriers that will be considered originate from the B vitamin group and are derivatives of nucleotides; they are...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...